Free tool
Healthcare stocks
We cover 1,104 companies in the Healthcare sector. The median market value in the group is $40.76M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is 0.00%. 40% of the 976 with a 200-day average trade above it. Price change over the past year runs from −76.7% to +63.0% across the middle 80 percent of the group, with a median of −16.5%. Among those 1,000, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,104 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.85% |
| GILD34.SA | Gilead Sciences, Inc. | $184.17B | Large cap | −78.95% |
| GIS.DE | Gilead Sciences, Inc. | $183.56B | Large cap | +29.53% |
| PFE.DE | Pfizer Inc. | $162.65B | Large cap | +18.09% |
| PFIZ34.SA | Pfizer Inc. | $161.64B | Large cap | +11.31% |
| PFE | Pfizer Inc. | $159.42B | Large cap | +19.52% |
| DHR | Danaher Corporation | $151.82B | Large cap | +4.52% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | −0.75% |
| DAP.DE | Danaher Corporation | $151.41B | Large cap | +5.45% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $140.77B | Large cap | +40.14% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $140.14B | Large cap | −83.17% |
| VRTX | Vertex Pharmaceuticals Incorporated | $140.04B | Large cap | +42.14% |
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| BRM.DE | Bristol-Myers Squibb Company | $138.39B | Large cap | +46.24% |
| IUI1.DE | Intuitive Surgical, Inc. | $133.35B | Large cap | −20.90% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −20.62% |
| I1SR34.SA | Intuitive Surgical, Inc. | $133.21B | Large cap | −24.38% |
| SYK | Stryker Corporation | $126.81B | Large cap | −14.79% |
| S1YK34.SA | Stryker Corporation | $126.62B | Large cap | −17.50% |
| SYK.DE | STRYKER CORP. R | $126.48B | Large cap | +34.76% |
| MDTC34.SA | Medtronic plc | $117.91B | Large cap | −76.08% |
| 2M6.DE | Medtronic plc | $117.39B | Large cap | +3.67% |
| MDT | Medtronic plc | $116.66B | Large cap | +1.33% |
| SNY | Sanofi | $110.27B | Large cap | −3.11% |
| SAN.PA | Sanofi | $110.15B | Large cap | −4.49% |
| SNW.DE | Sanofi | $109.49B | Large cap | −4.28% |
| MCK | McKesson Corporation | $105.52B | Large cap | +33.71% |
| GS71.DE | GSK plc | $104.54B | Large cap | +31.93% |
| G1SK34.SA | GSK plc | $104.53B | Large cap | +28.14% |
| GSK | GSK plc | $104.29B | Large cap | +34.79% |
| GSK.L | GSK plc | $104.16B | Large cap | +28.03% |
| M1CK34.SA | McKesson Corporation | $101.65B | Large cap | −92.48% |
| HCA | HCA Healthcare, Inc. | $95.12B | Large cap | +6.96% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +3.95% |
| A58.DE | Elevance Health, Inc. | $86.73B | Large cap | −18.92% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| ELV | Elevance Health, Inc. | $86.50B | Large cap | +29.17% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $86.30B | Large cap | −7.35% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.86B | Large cap | −38.59% |
| REGN | Regeneron Pharmaceuticals, Inc. | $85.82B | Large cap | +46.21% |
| EL.PA | EssilorLuxottica Société anonyme | $85.41B | Large cap | −37.89% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.24B | Large cap | +37.96% |
| CI | The Cigna Group | $73.81B | Large cap | −5.62% |
| C1IC34.SA | The Cigna Group | $73.40B | Large cap | −85.51% |
| CGN.DE | The Cigna Group | $73.25B | Large cap | −8.36% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $73.00B | Large cap | +12.47% |
| B1SX34.SA | Boston Scientific Corporation | $72.28B | Large cap | −88.79% |
| BSX | Boston Scientific Corporation | $72.26B | Large cap | −52.56% |
| BSX.DE | Boston Scientific Corporation | $71.57B | Large cap | −54.21% |
| MRK.DE | Merck KGaA | $70.75B | Large cap | +30.60% |
| ARGX | argenx SE | $63.78B | Large cap | +50.52% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +494.34% |
| 0QF.DE | Moderna, Inc. | $63.46B | Large cap | +461.14% |
| MRNA | Moderna, Inc. | $63.41B | Large cap | +526.55% |
| A1RG34.SA | argenx SE | $63.17B | Large cap | +44.49% |
| COR | Cencora, Inc. | $62.60B | Large cap | +14.44% |
| CSL.AX | CSL Limited | $59.98B | Large cap | −17.14% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.99B | Large cap | +39.50% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +21.77% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.23B | Large cap | +16.07% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.51B | Large cap | +71.10% |
| CAH | Cardinal Health, Inc. | $55.33B | Large cap | +64.25% |
| C1AH34.SA | Cardinal Health, Inc. | $55.24B | Large cap | +50.94% |
| BAY.WA | Bayer Aktiengesellschaft | $55.03B | Large cap | +71.25% |
| 207940.KS | Samsung Biologics Co.,Ltd. | $53.31B | Large cap | +2.60% |
| C1CO34.SA | Cencora, Inc. | $52.36B | Large cap | −12.17% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.38% |
| BOX.DE | Becton, Dickinson and Company | $52.05B | Large cap | +2.94% |
| EWL.DE | Edwards Lifesciences Corporation | $51.93B | Large cap | +10.23% |
| SHL.DE | Siemens Healthineers AG | $51.88B | Large cap | −12.35% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| BDX | Becton, Dickinson and Company | $51.69B | Large cap | +26.17% |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +29.26% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| MDLN | Medline Inc. | $46.69B | Large cap | −13.07% |
| HUM | Humana Inc. | $46.42B | Large cap | +32.71% |
| H1UM34.SA | Humana Inc. | $45.80B | Large cap | +24.30% |
| RVMD | Revolution Medicines, Inc. | $45.35B | Large cap | +492.60% |
| HLN | Haleon plc | $44.77B | Large cap | +6.56% |
| H6D0.DE | Haleon plc | $44.53B | Large cap | +4.86% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.40B | Large cap | +110.26% |
| HLN.L | Haleon plc | $44.36B | Large cap | +2.08% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −16.38% |
| IDXX | IDEXX Laboratories, Inc. | $43.39B | Large cap | −14.24% |
| A | Agilent Technologies, Inc. | $43.33B | Large cap | +30.69% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $43.18B | Large cap | +94.70% |
| IX1.DE | IDEXX Laboratories, Inc. | $43.12B | Large cap | +17.97% |
| IQV | IQVIA Holdings Inc. | $42.70B | Large cap | +37.97% |
| QTS.DE | IQVIA Holdings Inc. | $42.69B | Large cap | −3.91% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −16.69% |
| WAT | Waters Corporation | $40.69B | Large cap | +38.63% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.62B | Large cap | +58.81% |
| VEEV | Veeva Systems Inc. | $40.09B | Large cap | −13.47% |
| VEE.DE | Veeva System Inc. R | $40.06B | Large cap | +13.96% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.11% |
| WATC34.SA | Waters Corporation | $36.36B | Large cap | +24.76% |
| ALC | Alcon Inc. | $35.47B | Large cap | −8.71% |
| RPRX | Royalty Pharma plc | $35.44B | Large cap | +75.10% |
| 2U3.DE | Alcon Inc. | $35.35B | Large cap | −10.05% |
| DC4.DE | DexCom, Inc. | $34.19B | Large cap | +21.55% |
| RMD | ResMed Inc. | $34.13B | Large cap | −16.58% |
| I1LM34.SA | Illumina, Inc. | $34.11B | Large cap | +113.13% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.73% |
| ILU.DE | Illumina, Inc. | $34.04B | Large cap | +119.28% |
| ILMN | Illumina, Inc. | $33.97B | Large cap | +125.76% |
| D1EX34.SA | DexCom, Inc. | $33.83B | Large cap | +11.74% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +17.38% |
| GEHC | GE HealthCare Technologies Inc. | $33.62B | Large cap | −0.78% |
| 4568.T | Daiichi Sankyo Company, Limited | $33.36B | Large cap | −15.95% |
| IDP.DE | Biogen Inc. | $32.80B | Large cap | +57.35% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.81% |
| BIIB | Biogen Inc. | $32.62B | Large cap | +61.90% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −45.88% |
| CNC | Centene Corporation | $32.11B | Large cap | +123.52% |
| ZTS | Zoetis Inc. | $31.94B | Large cap | −49.59% |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +13.47% |
| Z1TS34.SA | Zoetis Inc. | $31.90B | Large cap | −52.14% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $31.87B | Large cap | −11.75% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.89% |
| ZOE.DE | Zoetis Inc. | $31.72B | Large cap | −50.09% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.15B | Large cap | +1.55% |
| 22UA.DE | BioNTech SE | $29.53B | Large cap | +8.53% |
| B1NT34.SA | BioNTech SE | $28.89B | Large cap | +3.26% |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.72% |
| MTO.DE | Mettler-Toledo International Inc. | $27.84B | Large cap | +13.15% |
| 4503.T | Astellas Pharma Inc. | $27.40B | Large cap | +56.44% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| R1MD34.SA | ResMed Inc. | $27.30B | Large cap | −38.24% |
| INSM | Insmed Incorporated | $27.07B | Large cap | −3.45% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| PHG | Koninklijke Philips N.V. | $26.81B | Large cap | +3.60% |
| PHI1.DE | Koninklijke Philips N.V. | $26.73B | Large cap | +2.84% |
| INCY | Incyte Corporation | $26.29B | Large cap | +53.04% |
| ROIV | Roivant Sciences Ltd. | $26.26B | Large cap | +213.32% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| WST | West Pharmaceutical Services, Inc. | $24.52B | Large cap | +41.31% |
| 4543.T | Terumo Corporation | $24.11B | Large cap | −1.19% |
| SIG.AX | Sigma Healthcare Limited | $23.62B | Large cap | −5.33% |
| STE | STERIS plc | $23.05B | Large cap | −4.35% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $22.07B | Large cap | +10.02% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $22.06B | Large cap | +10.46% |
| GH | Guardant Health, Inc. | $21.90B | Large cap | +166.52% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +54.57% |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% |
| GE9.DE | GENMAB AS N | $21.11B | Large cap | −14.41% |
| GMAB.CO | Genmab A/S | $21.08B | Large cap | +33.08% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.88B | Large cap | +26.10% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| VTRS | Viatris Inc. | $19.20B | Large cap | +62.88% |
| VIA.DE | Viatris Inc. | $19.14B | Large cap | +62.09% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.12B | Large cap | −5.86% |
| QS51.DE | Straumann Holding AG | $18.25B | Large cap | +0.41% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $17.32B | Large cap | +54.48% |
| MEDP | Medpace Holdings, Inc. | $17.31B | Large cap | +31.55% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +108.87% |
| ASND | Ascendis Pharma A/S | $16.59B | Large cap | +32.89% |
| COLO-B.CO | Coloplast A/S | $16.31B | Large cap | −20.81% |
| CBHD.DE | Coloplast A/S | $16.19B | Large cap | +7.28% |
| IPN.PA | Ipsen S.A. | $16.01B | Large cap | +39.21% |
| BBIO | BridgeBio Pharma, Inc. | $15.85B | Large cap | +70.01% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.80B | Large cap | +13.60% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.72B | Large cap | +22.06% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | $15.69B | Large cap | +7.58% |
| 4507.T | Shionogi & Co., Ltd. | $15.68B | Large cap | +17.95% |
| SOLV | Solventum Corporation | $15.59B | Large cap | +25.92% |
| NBIX | Neurocrine Biosciences, Inc. | $15.59B | Large cap | +14.46% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $15.25B | Large cap | +5.51% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.30% |
| ERF.PA | Eurofins Scientific SE | $14.91B | Large cap | +13.76% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +26.42% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −0.60% |
| CRL | Charles River Laboratories International, Inc. | $14.21B | Large cap | +81.37% |
| PME.AX | Pro Medicus Limited | $14.09B | Large cap | −38.33% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +49.66% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +35.78% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +2.30% |
| BAX | Baxter International Inc. | $13.59B | Large cap | +7.91% |
| ICLR | ICON Public Limited Company | $13.38B | Large cap | −1.65% |
| CORT | Corcept Therapeutics Incorporated | $13.36B | Large cap | +79.56% |
| ORNBV.HE | Orion Oyj | $13.29B | Large cap | +16.59% |
| ORNAV.HE | Orion Oyj | $13.24B | Large cap | +17.12% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.80B | Large cap | +13.03% |
| PEN | Penumbra, Inc. | $12.75B | Large cap | +22.79% |
| FME.DE | Fresenius Medical Care AG | $12.66B | Large cap | −3.50% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.60B | Large cap | +2.09% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +6.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +329.16% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.29% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +51.39% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −9.45% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $12.20B | Large cap | +41.03% |
| SN.L | Smith & Nephew plc | $12.20B | Large cap | −21.69% |
| EHC | Encompass Health Corporation | $11.85B | Large cap | −1.16% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $11.83B | Large cap | +24.24% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| DVA | DaVita Inc. | $11.41B | Large cap | +29.47% |
| ALGN | Align Technology, Inc. | $11.34B | Large cap | +10.11% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +137.67% |
| AFW.DE | Align Technology, Inc. | $11.31B | Large cap | −54.37% |
| TECH | Bio-Techne Corporation | $11.27B | Large cap | +28.12% |
| T1CH34.SA | Bio-Techne Corporation | $11.23B | Large cap | +23.42% |
| GMED | Globus Medical, Inc. | $11.14B | Large cap | +35.16% |
| DVAI34.SA | DaVita Inc. | $11.11B | Large cap | +15.68% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| CYTK | Cytokinetics, Incorporated | $10.77B | Large cap | +109.29% |
| AXSM | Axsome Therapeutics, Inc. | $10.76B | Large cap | +76.67% |
| GKOS | Glaukos Corporation | $10.70B | Large cap | +98.13% |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +52.01% |
| KRYS | Krystal Biotech, Inc. | $10.54B | Large cap | +142.69% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +202.82% |
| BIO | Bio-Rad Laboratories, Inc. | $10.45B | Large cap | +31.26% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.44% |
| ABVX.PA | ABIVAX Société Anonyme | $10.42B | Large cap | +42.59% |
| MOH | Molina Healthcare, Inc. | $10.42B | Large cap | +13.96% |
| BIM.PA | bioMérieux S.A. | $10.40B | Large cap | −37.52% |
| UHS | Universal Health Services, Inc. | $10.40B | Large cap | −4.14% |
| ABVX | ABIVAX Société Anonyme | $10.29B | Large cap | +52.25% |
| RDY | Dr. Reddy's Laboratories Limited | $10.28B | Large cap | −14.66% |
| PRAX | Praxis Precision Medicines, Inc. | $10.28B | Large cap | +684.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +49.84% |
| HSIC | Henry Schein, Inc. | $10.21B | Large cap | +30.93% |
| U1HS34.SA | Universal Health Services, Inc. | $10.21B | Large cap | −10.02% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +265.05% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +0.44% |
| PTGX | Protagonist Therapeutics, Inc. | $10.01B | Large cap | +164.75% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +67.33% |
| GOSS | Gossamer Bio, Inc. | $99.97M | Micro cap | −91.33% |
| ILA.AX | Island Pharmaceuticals Limited | $99.59M | Micro cap | +104.35% |
| 4BB.L | 4basebio PLC | $99.32M | Micro cap | −46.89% |
| NANOFS.ST | Nanoform Finland Oyj | $99.24M | Micro cap | +12.70% |
| ATRA | Atara Biotherapeutics, Inc. | $98.77M | Micro cap | −19.61% |
| PARK | Park Dental Partners, Inc. | $98.64M | Micro cap | +99.61% |
| CGTX | Cognition Therapeutics, Inc. | $97.95M | Micro cap | −67.61% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $97.76M | Micro cap | +14.33% |
| 4563.T | AnGes, Inc. | $97.73M | Micro cap | −56.67% |
| ABNX.PA | ABIONYX Pharma SA | $97.56M | Micro cap | −16.20% |
| 88Q.DE | 4basebio PLC | $96.74M | Micro cap | −46.70% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $96.60M | Micro cap | −22.41% |
| NANOFH.HE | Nanoform Finland Oyj | $96.13M | Micro cap | +13.49% |
| 4575.T | CanBas Co., Ltd. | $96.08M | Micro cap | −40.51% |
| BIOPOR.CO | BioPorto A/S | $95.88M | Micro cap | −6.25% |
| ADOC.PA | Adocia SA | $94.62M | Micro cap | −46.72% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +23.58% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.66% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.17% |
| BB1.AX | BLINKLAB FPO [BB1] | $93.89M | Micro cap | +67.65% |
| ALDX | Aldeyra Therapeutics, Inc. | $93.51M | Micro cap | −73.14% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +63.91% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +4.58% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $92.86M | Micro cap | −8.15% |
| ALC.AX | Alcidion Group Limited | $92.38M | Micro cap | −7.62% |
| HYPR | Hyperfine, Inc. | $92.24M | Micro cap | −30.42% |
| INIFY.OL | INIFY Laboratories AB | $91.74M | Micro cap | +34.00% |
| VISTN.OL | Vistin Pharma ASA | $91.18M | Micro cap | −15.47% |
| SGMO | Sangamo Therapeutics, Inc. | $91.14M | Micro cap | −56.86% |
| DWTX | Dogwood Therapeutics, Inc. | $91.10M | Micro cap | −47.04% |
| 4350.T | Medical System Network Co., Ltd. | $90.54M | Micro cap | +6.47% |
| NANEXA.ST | Nanexa AB (publ) | $90.50M | Micro cap | +109.51% |
| 4978.T | ReproCELL Incorporated | $90.50M | Micro cap | −17.32% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | $90.27M | Micro cap | +10.80% |
| EAH.L | ECO Animal Health Group plc | $90.13M | Micro cap | +37.41% |
| CVRX | CVRx, Inc. | $89.78M | Micro cap | −54.77% |
| 7V0.DE | Novogenia AG | $89.68M | Micro cap | −29.07% |
| RLYB | Rallybio Corporation | $89.67M | Micro cap | +262.65% |
| 3417.T | Ohki Healthcare Holdings Co.,Ltd. | $89.57M | Micro cap | −15.91% |
| ICCC | ImmuCell Corporation | $89.37M | Micro cap | +61.58% |
| ACH | Accendra Health, Inc. | $89.21M | Micro cap | −77.39% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $88.96M | Micro cap | −23.95% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $88.88M | Micro cap | +76.27% |
| OSE.PA | OSE Immunotherapeutics SA | $88.77M | Micro cap | −47.82% |
| 6678.T | Techno Medica Co., Ltd. | $88.56M | Micro cap | +10.19% |
| 194A.T | WOLVES HAND CO LTD | $88.26M | Micro cap | +100.75% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | $88.25M | Micro cap | +246.15% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | $87.90M | Micro cap | −21.42% |
| 002390.KS | HANDOK Inc. | $87.90M | Micro cap | −20.23% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.29M | Micro cap | −52.27% |
| TENX | Tenax Therapeutics, Inc. | $86.82M | Micro cap | −60.81% |
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% |
| MAIA | MAIA Biotechnology, Inc. | $85.78M | Micro cap | −10.76% |
| CTOR | Citius Oncology, Inc. | $85.68M | Micro cap | −57.14% |
| ECOR | electroCore, Inc. | $85.38M | Micro cap | +79.70% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +39.60% |
| CREO.L | Creo Medical Group PLC | $85.36M | Micro cap | −1.90% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | $85.35M | Micro cap | −10.10% |
| EQL.ST | EQL Pharma AB | $84.50M | Micro cap | −67.71% |
| ACET | Adicet Bio, Inc. | $84.25M | Micro cap | −20.89% |
| HIGH.DE | Cantourage Group SE | $83.91M | Micro cap | +45.19% |
| VRCA | Verrica Pharmaceuticals Inc. | $83.66M | Micro cap | −17.53% |
| 7792.T | Colan Totte.Co.,Ltd. | $83.45M | Micro cap | +4.31% |
| OBI.L | Ondine Biomedical Inc. | $83.31M | Micro cap | −25.76% |
| AB.PA | AB Science S.A. | $83.30M | Micro cap | −44.83% |
| RPID | Rapid Micro Biosystems, Inc. | $83.26M | Micro cap | −37.12% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | +3.53% |
| 002620.KS | Jeil Pharma Holdings Inc | $83.00M | Micro cap | −14.27% |
| POLB.L | Poolbeg Pharma PLC | $82.75M | Micro cap | +161.54% |
| HLS.TO | HLS Therapeutics Inc. | $82.45M | Micro cap | −26.86% |
| 4888.T | Stella Pharma Corporation | $82.15M | Micro cap | −9.23% |
| OKYO | OKYO Pharma Limited | $81.87M | Micro cap | −35.80% |
| TELO | Telomir Pharmaceuticals, Inc. | $81.15M | Micro cap | −19.18% |
| ATH.AX | Alterity Therapeutics Limited | $81.04M | Micro cap | −20.00% |
| ATHE | Alterity Therapeutics Limited | $81.02M | Micro cap | −12.35% |
| RCE.AX | Recce Pharmaceuticals Ltd | $81.01M | Micro cap | −12.79% |
| OM | Outset Medical, Inc. | $80.92M | Micro cap | −68.62% |
| DH | Definitive Healthcare Corp. | $80.51M | Micro cap | −81.10% |
| CRDF | Cardiff Oncology, Inc. | $79.35M | Micro cap | −53.85% |
| OMDA.OL | Omda AS | $79.27M | Micro cap | −27.31% |
| ELTX | Elicio Therapeutics, Inc. | $79.11M | Micro cap | −72.71% |
| DICOT.ST | Dicot Pharma AB | $78.52M | Micro cap | −76.93% |
| NXTMH.HE | Nexstim Plc | $78.40M | Micro cap | −30.34% |
| MDG.WA | Medicalgorithmics S.A. | $77.94M | Micro cap | −21.33% |
| ANVS | Annovis Bio, Inc. | $77.54M | Micro cap | −18.75% |
| MNOV | MediciNova, Inc. | $77.28M | Micro cap | +18.94% |
| 7775.T | Daiken Medical Co., Ltd. | $77.26M | Micro cap | −3.06% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +318.64% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −24.66% |
| NRXS | NeurAxis, Inc. | $76.23M | Micro cap | +137.80% |
| ZTEK | Zentek Ltd. | $76.16M | Micro cap | −7.46% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.37% |
| 7097.T | SAKURASAKU PLUS,Co.,Ltd. | $75.31M | Micro cap | −0.70% |
| 4875.T | MediciNova, Inc. | $75.15M | Micro cap | +15.24% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −23.49% |
| IBIO | iBio, Inc. | $73.03M | Micro cap | +72.94% |
| KOO.L | Kooth plc | $72.99M | Micro cap | −6.94% |
| DRIO | DarioHealth Corp. | $72.42M | Micro cap | −32.82% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +141.55% |
| STX.L | Shield Therapeutics plc | $70.81M | Micro cap | −41.98% |
| SPRO | Spero Therapeutics, Inc. | $70.76M | Micro cap | −33.51% |
| SAR.L | Sareum Holdings plc | $70.74M | Micro cap | +38.10% |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −28.13% |
| ALTHX.PA | THX Pharma Société Anonyme | $70.40M | Micro cap | +89.35% |
| 7702.T | JMS Co.,Ltd. | $70.30M | Micro cap | +6.67% |
| 2689.T | OLBA HEALTHCARE HOLDINGS, Inc. | $69.91M | Micro cap | −7.22% |
| EXOZ | eXoZymes, Inc. | $69.89M | Micro cap | −19.12% |
| PMVP | PMV Pharmaceuticals, Inc. | $69.76M | Micro cap | −8.10% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +254.22% |
| ZLNA.OL | Zelluna ASA | $69.57M | Micro cap | +45.70% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | $69.28M | Micro cap | +30.77% |
| CSBR | Champions Oncology, Inc. | $69.19M | Micro cap | −29.46% |
| 9341.T | GENOVA, Inc. | $69.07M | Micro cap | +2.20% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −32.20% |
| NNOX | Nano-X Imaging Ltd. | $67.82M | Micro cap | −77.81% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $67.70M | Micro cap | −19.23% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | $67.44M | Micro cap | −15.92% |
| INMB | INmune Bio Inc. | $67.44M | Micro cap | +8.48% |
| BOLD | Boundless Bio, Inc. | $67.33M | Micro cap | +160.18% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +2.98% |
| 2934.T | J Frontier Co.,Ltd. | $66.96M | Micro cap | +5.78% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −52.13% |
| MAAT.PA | MaaT Pharma SA | $66.80M | Micro cap | −39.58% |
| HYFT | MindWalk Holdings Corp. | $66.72M | Micro cap | −48.55% |
| ONCO.ST | Oncopeptides AB (publ) | $66.64M | Micro cap | −65.91% |
| HEALTH.HE | Nightingale Health Oyj | $65.41M | Micro cap | −58.91% |
| LTP.AX | LTR PHARMA FPO [LTP] | $65.08M | Micro cap | −2.00% |
| GENT.OL | Gentian Diagnostics ASA | $64.73M | Micro cap | −30.56% |
| AJ91.DE | DocCheck AG | $64.58M | Micro cap | −9.24% |
| LYTIX.OL | Lytix Biopharma ASA | $64.24M | Micro cap | −14.82% |
| ALGAE.PA | FERMENTALG | $64.20M | Micro cap | −10.79% |
| R0L.F | J Frontier Co.,Ltd. | $64.15M | Micro cap | −43.48% |
| RNXT | RenovoRx, Inc. | $64.08M | Micro cap | +58.13% |
| TLPH | Talphera, Inc. | $63.84M | Micro cap | +108.77% |
| IMA | ImageneBio, Inc. | $63.80M | Micro cap | −60.78% |
| SEZI.ST | Senzime AB (publ) | $62.78M | Micro cap | −41.72% |
| AHC.AX | Austco Healthcare Limited | $61.76M | Micro cap | −36.11% |
| 3079.T | DVx Inc. | $61.76M | Micro cap | −7.86% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | $61.74M | Micro cap | +124.11% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $61.73M | Micro cap | +31.66% |
| HRTX | Heron Therapeutics, Inc. | $61.34M | Micro cap | −76.59% |
| HVO.L | hVIVO plc | $61.06M | Micro cap | −34.60% |
| 4263.T | SUSMED,Inc. | $60.39M | Micro cap | −29.83% |
| INKT | MiNK Therapeutics, Inc. | $60.32M | Micro cap | −21.89% |
| 9265.T | Yamashita Health Care Holdings,Inc. | $59.98M | Micro cap | +24.36% |
| XLO | Xilio Therapeutics, Inc. | $59.75M | Micro cap | −7.35% |
| NTRB | Nutriband Inc. | $58.71M | Micro cap | −24.59% |
| MYO | Myomo, Inc. | $58.62M | Micro cap | +35.78% |
| DXR | Daxor Corporation | $58.38M | Micro cap | −7.83% |
| V3V.DE | FamiCord AG | $58.21M | Micro cap | −60.69% |
| 3446.T | JTEC Corporation | $58.17M | Micro cap | +29.85% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | $57.90M | Micro cap | −2.93% |
| EPIS-B.ST | Episurf Medical AB (publ) | $57.85M | Micro cap | +73.96% |
| 4524.T | Morishita Jintan Co., Ltd. | $57.77M | Micro cap | +4.07% |
| FLUO.ST | FluoGuide A/S | $57.76M | Micro cap | −21.07% |
| COCH | Envoy Medical, Inc. | $57.66M | Micro cap | −33.30% |
| SRTS | Sensus Healthcare, Inc. | $57.45M | Micro cap | +7.35% |
| BVC.L | BATM Advanced Communications Ltd. | $57.08M | Micro cap | −24.80% |
| IMM.AX | Immutep Limited | $57.02M | Micro cap | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | $56.97M | Micro cap | −13.53% |
| 7776.T | CellSeed Inc. | $56.74M | Micro cap | −47.42% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +15.89% |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% |
| ATYR | aTyr Pharma, Inc. | $55.91M | Micro cap | −88.95% |
| 4584.T | Kidswell Bio Corporation | $55.83M | Micro cap | −24.37% |
| 4572.T | Carna Biosciences, Inc. | $55.69M | Micro cap | +83.26% |
| GNTA | Genenta Science S.p.A. | $55.45M | Micro cap | −67.05% |
| COIL.L | Coiled Therapeutics plc | $55.33M | Micro cap | −26.92% |
| AVE.AX | Avecho Biotechnology Limited | $55.33M | Micro cap | +200.00% |
| 7963.T | Koken Ltd. | $55.27M | Micro cap | +5.49% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| TELY.TO | TelyRx Holdings Inc. | $54.78M | Micro cap | −18.57% |
| ALKLH.PA | KLEA HOLDING | $54.68M | Micro cap | −29.55% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.61M | Micro cap | +13.48% |
| 4571.T | Nano Holdings, Inc. | $54.57M | Micro cap | −30.00% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $54.28M | Micro cap | −47.65% |
| ALTHE.PA | Theraclion SA | $54.11M | Micro cap | −20.00% |
| OHGR.L | One Health Group Plc | $54.00M | Micro cap | +17.03% |
| XSPRAY.ST | Xspray Pharma AB (publ) | $53.87M | Micro cap | −76.41% |
| 4564.T | OncoTherapy Science, Inc. | $53.87M | Micro cap | −25.00% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $53.78M | Micro cap | +81.25% |
| BTMD | biote Corp. | $53.56M | Micro cap | −51.08% |
| SOM.AX | SomnoMed Limited | $53.50M | Micro cap | −56.13% |
| 000230.KS | Ildong Holdings Co., Ltd. | $53.47M | Micro cap | −27.92% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +24.78% |
| 063160.KS | CKD Bio Corp. | $53.33M | Micro cap | −39.08% |
| HYPD | Hyperion DeFi, Inc. | $52.99M | Micro cap | −44.10% |
| ALA.AX | Arovella Therapeutics Limited | $52.84M | Micro cap | −26.19% |
| MODU.HE | Modulight Oyj | $52.83M | Micro cap | −23.38% |
| HRTIS.HE | Herantis Pharma Oyj | $52.30M | Micro cap | −4.21% |
| CLBIO.ST | Corline Biomedical AB | $52.11M | Micro cap | +46.22% |
| TCRX | TScan Therapeutics, Inc. | $51.87M | Micro cap | −58.23% |
| SCYX | SCYNEXIS, Inc. | $51.64M | Micro cap | +514.20% |
| TIL | Instil Bio, Inc. | $51.54M | Micro cap | −69.62% |
| MDAI | Spectral AI, Inc. | $51.50M | Micro cap | −19.70% |
| 4597.T | Solasia Pharma K.K. | $51.47M | Micro cap | −23.68% |
| 004720.KS | PharmGen Science, Inc. | $51.24M | Micro cap | −27.52% |
| 9218.T | Mental Health Technologies Co.,Ltd. | $51.10M | Micro cap | −5.89% |
| AIFORIA.HE | Aiforia Technologies Oyj | $51.08M | Micro cap | −66.16% |
| M3V.DE | MeVis Medical Solutions AG | $50.58M | Micro cap | −0.42% |
| PTX.AX | Prescient Therapeutics Limited | $50.48M | Micro cap | +58.14% |
| ORX.ST | Orexo AB (publ) | $50.31M | Micro cap | −36.19% |
| CANTA.ST | Cantargia AB (publ) | $50.23M | Micro cap | −28.93% |
| SVS.MI | Svas Biosana S.p.A. | $50.15M | Micro cap | +0.73% |
| PHX.AX | PharmX Technologies Limited | $50.12M | Micro cap | −4.55% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −20.79% |
| 8769.T | Advantage Risk Management Co., Ltd. | $49.53M | Micro cap | −11.34% |
| 002720.KS | Kukje Pharma Co., Ltd. | $49.51M | Micro cap | −29.89% |
| ENZY.ST | Enzymatica AB (publ) | $48.79M | Micro cap | −21.61% |
| 7096.T | StemCell Institute Inc. | $48.78M | Micro cap | −21.54% |
| POCI | Precision Optics Corporation, Inc. | $48.27M | Micro cap | −9.07% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −48.69% |
| M7T.AX | Mach7 Technologies Limited | $47.99M | Micro cap | −9.52% |
| SVE.WA | Synthaverse S.A. | $47.84M | Micro cap | −37.70% |
| IMMU.ST | Mendus AB (publ) | $47.68M | Micro cap | −8.16% |
| 3628.T | Data Horizon Co.,Ltd. | $47.53M | Micro cap | +9.96% |
| QTI | QT Imaging Holdings, Inc. | $47.42M | Micro cap | −90.73% |
| 3671.T | Softmax Co., Ltd | $47.30M | Micro cap | −7.57% |
| CYC.AX | Cyclopharm Limited | $46.85M | Micro cap | −47.50% |
| OSSD.ST | OssDsign AB (publ) | $46.81M | Micro cap | −71.22% |
| MCRB | Seres Therapeutics, Inc. | $46.81M | Micro cap | −74.00% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −26.84% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −32.31% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.25M | Micro cap | −33.75% |
| BIOBV.HE | Biohit Oyj | $46.16M | Micro cap | −8.24% |
| FLNA | Filana Therapeutics, Inc. | $45.83M | Micro cap | −56.07% |
| NEPH | Nephros, Inc. | $45.83M | Micro cap | +0.72% |
| AIAI.TO | NetraMark Holdings Inc. | $45.79M | Micro cap | −59.54% |
| MGX | Metagenomi Therapeutics, Inc. | $45.71M | Micro cap | −35.64% |
| ENP.AX | Entropy Neurodynamics Limited | $45.59M | Micro cap | +5.41% |
| 4890.T | Tsubota Laboratory Incorporated | $45.38M | Micro cap | −23.50% |
| ABLD.PA | ABL Diagnostics Société anonyme | $45.06M | Micro cap | −47.32% |
| MREO | Mereo BioPharma Group plc | $44.97M | Micro cap | −83.82% |
| XTNT | Xtant Medical Holdings, Inc. | $44.88M | Micro cap | −50.02% |
| IXHL | Incannex Healthcare Inc. | $44.87M | Micro cap | −83.13% |
| 3386.T | Cosmo Bio Company,Limited | $44.68M | Micro cap | +6.78% |
| TVGN | Tevogen Inc. | $44.34M | Micro cap | −84.85% |
| 2370.T | MEDINET Co., Ltd. | $44.25M | Micro cap | −34.21% |
| 6059.T | UCHIYAMA HOLDINGS Co.,Ltd. | $43.89M | Micro cap | +12.60% |
| 9340.T | ASO International, Inc. | $43.88M | Micro cap | −1.19% |
| CTE.AX | Cryosite Limited | $43.72M | Micro cap | +56.25% |
| 3750.T | ADR Biomedical Holdings Inc. | $43.59M | Micro cap | −15.61% |
| ALCOX.PA | Nicox S.A. | $43.20M | Micro cap | +4.08% |
| 4880.T | CellSource Co., Ltd. | $43.15M | Micro cap | −41.78% |
| ALNOV.PA | Novacyt S.A. | $43.09M | Micro cap | +8.44% |
| NCYT.L | Novacyt S.A. | $43.04M | Micro cap | +9.18% |
| MLSS | Milestone Scientific Inc. | $43.04M | Micro cap | −17.80% |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% |
| EDSA | Edesa Biotech, Inc. | $42.90M | Micro cap | +83.88% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.57% |
| 000220.KS | Yuyu Pharma, Inc. | $42.74M | Micro cap | −11.54% |
| OPTOMED.HE | Optomed Oyj | $42.69M | Micro cap | −54.67% |
| VVEO3.SA | CM Hospitalar S/A | $42.35M | Micro cap | −24.18% |
| ELUT | Elutia Inc. | $42.30M | Micro cap | −57.74% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $42.19M | Micro cap | −69.57% |
| MVP.AX | Medical Developments International Limited | $41.73M | Micro cap | −13.01% |
| PMED.MI | Piu' Medical | $41.52M | Micro cap | −3.55% |
| LGP.AX | Little Green Pharma Ltd | $41.50M | Micro cap | −44.00% |
| MOC.WA | Molecure S.A. | $41.14M | Micro cap | −21.18% |
| SHG.AX | Singular Health Group Ltd | $40.89M | Micro cap | −47.76% |
| ONCIN.OL | Oncoinvent ASA | $40.87M | Micro cap | +11.35% |
| PAVM | PAVmed Inc. | $40.78M | Micro cap | −64.04% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.